Evidence map›Paper›PMID 16247007›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Breath sulfides and pulmonary function in cystic fibrosis.

M A Kamboures, D R Blake, D M Cooper, R L Newcomb, M Barker, J K Larson, S Meinardi, E Nussbaum, F S Rowland

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Progress toward colorimetric and fluorescent detection of carbonyl sulfide.Chemical communications (Cambridge, England) · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

M A KambouresDepartment of Chemistry, University of California, Irvine, CA 92697-2025, USA.
D R Blake
D M Cooper
R L Newcomb
M Barker
J K Larson
S Meinardi
E Nussbaum
F S Rowland
University of California, Irvine · USLong Beach Memorial Medical Center · USMiller Children's & Women's Hospital · US

Funding

PBMCs, Exercise, and Children: Initial MechanismsR01HL080947 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M · 2005 to 2009
$3.4M
MECHANISMS OF EXERCISE MODULATION OF HUMAN GROWTHR01HD026939 · NICHD · UNIVERSITY OF CALIFORNIA IRVINE · PI COOPER, DAN M · 1991 to 2004
$2.0M
NHLBI NIH HHS HL 080947NHLBI NIH HHS R01 HL080947NICHD NIH HHS HD 26939NICHD NIH HHS R01 HD026939
6 · The paper itself

Abstract

We have determined the concentrations of carbonyl sulfide (OCS), dimethylsulfide, and carbon disulfide (CS(2)) in the breath of a group of cystic fibrosis (CF) patients and one of healthy controls. At the detection sensitivity in these experiments, room air always contained measurable quantities of these three gases. For each subject the inhaled room concentrations were subtracted from the time-coincident concentrations in exhaled breath air. The most significant differences between the CF and control cohorts in these breath-minus-room values were found for OCS. The control group demonstrated a net uptake of 250 +/- 20 parts-per-trillion-by-volume (pptv), whereas the CF cohort had a net uptake of 110 +/- 60 pptv (P = 0.00003). Three CF patients exhaled more OCS than they inhaled from the room. The OCS concentrations in the CF cohort were strongly correlated with pulmonary function. The dimethylsulfide concentrations in breath were greatly enhanced over ambient, but no significant difference was observed between the CF and healthy control groups. The net (breath minus room) CS(2) concentrations for individuals ranged between +180 and -100 pptv. They were slightly greater in the CF cohort (+26 +/- 38 pptv) vs. the control group (-17 +/- 15 pptv; P = 0.04). Lung disease in CF is accompanied by the subsistence of chronic bacterial infections. Sulfides are known to be produced by bacteria in various systems and were therefore the special target for this investigation. Our results suggest that breath sulfide content deserves attention as a noninvasive marker of respiratory colonization.

Indexed as

AdolescentAdultBreath TestsCarbon DisulfideCase-Control StudiesChildCystic FibrosisFemaleHumansMaleRespiratory Function TestsRespiratory SystemSulfidesSulfur OxidesCarbon Disulfidecarbonyl sulfidedimethyl sulfideSulfidesSulfur Oxides

Identifiers

PMID16247007
PMCPMC1276081
OpenAlexW2158102842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.